| 1 |
Exosomes from EGFR-Mutated Adenocarcinoma Induce a Hybrid EMT and MMP9-Dependant Tumor Invasion |
|
| | Amina Jouida, Marissa O’Callaghan, Cormac Mc Carthy, Aurelie Fabre, Parthiban Nadarajan, Michael P. Keane | | | Cancers. 2022; 14(15): 3776 | | | [Pubmed] [Google Scholar] [DOI] | | | 2 |
EGFR T751_I759delinsN Mutation in Exon19 Detected by NGS but Not by Real-Time PCR in a Heavily-Treated Patient with NSCLC |
|
| | Zi-Ting Chang, Tien-Ming Chan, Chiao-En Wu | | | International Journal of Molecular Sciences. 2022; 23(21): 13451 | | | [Pubmed] [Google Scholar] [DOI] | | | 3 |
Molecular Epidemiology of the Main Druggable Genetic Alterations in Non-Small Cell Lung Cancer |
|
| | Sara S. Fois, Panagiotis Paliogiannis, Angelo Zinellu, Alessandro G. Fois, Antonio Cossu, Giuseppe Palmieri | | | International Journal of Molecular Sciences. 2021; 22(2): 612 | | | [Pubmed] [Google Scholar] [DOI] | | | 4 |
Exosomes: a new perspective in EGFR-mutated lung cancer |
|
| | Amina Jouida, Cormac McCarthy, Aurelie Fabre, Michael P. Keane | | | Cancer and Metastasis Reviews. 2021; 40(2): 589 | | | [Pubmed] [Google Scholar] [DOI] | | | 5 |
Targeting alveolar macrophages shows better treatment response than deletion of interstitial macrophages in EGFR mutant lung adenocarcinoma |
|
| | Kristina Alikhanyan, Yuanyuan Chen, Simone Kraut, Rocio Sotillo | | | Immunity, Inflammation and Disease. 2020; 8(2): 181 | | | [Pubmed] [Google Scholar] [DOI] | |
|
